
Irfan Gulam Ahmed Dhorajiwala
About Irfan Gulam Ahmed Dhorajiwala
Data last updated:
Irfan Gulam Ahmed Dhorajiwala is a Director at Thaiger Pharma Private Limited (since 2014), Director at Nova Laboratories Private Limited (since 2017) and Director at Thaiger Nutraceuticals Private Limited (since 2017), and holds 2 more current directorships. The companies operate in Pharma, Food and Beverages and Real Estate. The 3 current companies with reported revenue have a combined latest revenue of ₹13.21 Cr; the largest is Thaiger Pharma Private Limited at ₹12.77 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Feb 2014 | 2014 | ₹12.77 Cr (FY 2025) | Active | |
| Director | 13 Jun 2017 | 2017 | ₹28.2 Lakh (FY 2025) | Active | |
| Director | 18 Apr 2017 | 2017 | ₹16.5 Lakh (FY 2023) | Active | |
| Designated Partner | 01 Sep 2025 | 2024 | Active | ||
| Designated Partner | 14 Aug 2025 | 2025 | Active |
Board colleagues of Irfan Gulam Ahmed Dhorajiwala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aftab Akhtar Attarwala | 10104871 | Thaiger Pharma Private Limited | Director |
| Chen Zhanzhi | 08585327 | Nova Laboratories Private Limited | Director |
| Peter Jerzy Franik | 08222121 | Nova Laboratories Private Limited , Thaiger Nutraceuticals Private Limited | Director |
| Reshma Irfan Ahmed | 06769975 | Nova Laboratories Private Limited , Thaiger Nutraceuticals Private Limited | Director |
| Afzal Mohammed Amin | 08470171 | Thaiger Built It Better Llp | Designated Partner |
| Sikander Hanif Shaikh | 11242577 | Thaiger Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Irfan Gulam Ahmed Dhorajiwala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Irfan Gulam Ahmed Dhorajiwala
Irfan Gulam Ahmed Dhorajiwala currently holds 5 directorships: Thaiger Pharma Private Limited (Director, since 17 Feb 2014, revenue ₹12.77 Cr (FY 2025)); Nova Laboratories Private Limited (Director, since 13 Jun 2017, revenue ₹28.2 Lakh (FY 2025)); Thaiger Nutraceuticals Private Limited (Director, since 18 Apr 2017, revenue ₹16.5 Lakh (FY 2023)); Thaiger Built It Better Llp (Designated Partner, since 01 Sep 2025); Thaiger Llp (Designated Partner, since 14 Aug 2025).
Irfan Gulam Ahmed Dhorajiwala was first appointed on 17 Feb 2014 as Director at Thaiger Pharma Private Limited. The most recent appointment on record is 01 Sep 2025 at Thaiger Built It Better Llp.
The 3 current companies of Irfan Gulam Ahmed Dhorajiwala that report revenue have a combined latest revenue of ₹13.21 Cr: Thaiger Pharma Private Limited ₹12.77 Cr (FY 2025); Nova Laboratories Private Limited ₹28.2 Lakh (FY 2025); Thaiger Nutraceuticals Private Limited ₹16.5 Lakh (FY 2023).
The current boards of Irfan Gulam Ahmed Dhorajiwala's companies include Aftab Akhtar Attarwala (Thaiger Pharma Private Limited), Chen Zhanzhi (Nova Laboratories Private Limited), Peter Jerzy Franik (Nova Laboratories Private Limited), Reshma Irfan Ahmed (Nova Laboratories Private Limited), Afzal Mohammed Amin (Thaiger Built It Better Llp), Sikander Hanif Shaikh (Thaiger Llp).